Bigfoot Biomedical has secured $57 million in financing as it works toward commercialising its diabetes management program. According to a press release, Madryn Asset Management
A pharmaceutical company has announced positive results from its phase Ib clinical study on its drug for neuropathic pain. AlzeCure develops a broad portfolio of
There’s plenty of news again in this issue. Despite adversity, many people in the diabetes arena are hard at it, which gives me plenty to
Owen Mumford has been appointed as the sole supplier for insulin safety pen needles by the NHS Wales Shared Services Partnership – Procurement Services, hosted by Velindre NHS Trust. Ateria SafeControl safety pen needles will now be
Alarmed about alarms? Don’t be…. We look at ‘alarm fatigue’ – what is it, how to avoid it, and what to do if you have
Spirit Pharmacy, the UK’s only home delivery pharmacy offering tailored services for people living with diabetes, has launched its free Live Well With Diabetes package.
A new series of videos on the self-monitoring of blood glucose (SMBG) has been published by the Association of British Clinical Diabetologists (ABCD). The Diabetes
Trial data reveals that children with Type 1 diabetes using a hybrid closed-loop system and their parents do not report an increase in diabetes-related burden
Approximately 9 in 10 specialists agree that people with Type 2 diabetes whose healthcare professionals (HCPs) collaborate tend to have better outcomes than those whose
A new emergency glucagon treatment is to become available in the United States from June 2021. Zegalogue – also known as dasiglucagon injection – was recently
